Lantheus Holdings Inc (LNTH)
79.28
-0.62
(-0.78%)
USD |
NASDAQ |
Jun 10, 16:00
79.50
+0.22
(+0.28%)
After-Hours: 20:00
Lantheus Holdings Enterprise Value: 5.383B for June 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 07, 2024 | 5.383B |
| June 06, 2024 | 5.505B |
| June 05, 2024 | 5.565B |
| June 04, 2024 | 5.495B |
| June 03, 2024 | 5.601B |
| May 31, 2024 | 5.517B |
| May 30, 2024 | 5.426B |
| May 29, 2024 | 5.374B |
| May 28, 2024 | 5.351B |
| May 24, 2024 | 5.267B |
| May 23, 2024 | 5.321B |
| May 22, 2024 | 5.483B |
| May 21, 2024 | 5.438B |
| May 20, 2024 | 5.589B |
| May 17, 2024 | 5.367B |
| May 16, 2024 | 5.466B |
| May 15, 2024 | 5.362B |
| May 14, 2024 | 5.300B |
| May 13, 2024 | 5.243B |
| May 10, 2024 | 5.114B |
| May 09, 2024 | 5.106B |
| May 08, 2024 | 5.009B |
| May 07, 2024 | 5.113B |
| May 06, 2024 | 5.079B |
| May 03, 2024 | 5.080B |
| Date | Value |
|---|---|
| May 02, 2024 | 5.264B |
| May 01, 2024 | 4.516B |
| April 30, 2024 | 4.457B |
| April 29, 2024 | 4.507B |
| April 26, 2024 | 4.389B |
| April 25, 2024 | 4.364B |
| April 24, 2024 | 4.364B |
| April 23, 2024 | 4.308B |
| April 22, 2024 | 4.215B |
| April 19, 2024 | 4.267B |
| April 18, 2024 | 4.164B |
| April 17, 2024 | 4.105B |
| April 16, 2024 | 4.123B |
| April 15, 2024 | 4.020B |
| April 12, 2024 | 4.057B |
| April 11, 2024 | 4.107B |
| April 10, 2024 | 3.993B |
| April 09, 2024 | 4.032B |
| April 08, 2024 | 3.985B |
| April 05, 2024 | 4.060B |
| April 04, 2024 | 3.987B |
| April 03, 2024 | 3.947B |
| April 02, 2024 | 3.924B |
| April 01, 2024 | 4.010B |
| March 31, 2024 | 4.158B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
462.97M
Minimum
Mar 18 2020
6.897B
Maximum
May 12 2023
2.843B
Average
1.938B
Median
Jul 12 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 568.22M |
| Boston Scientific Corp | 121.89B |
| Align Technology Inc | 18.34B |
| Edwards Lifesciences Corp | 52.08B |
| Stryker Corp | 143.54B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 131.07M |
| Revenue (Quarterly) | 369.98M |
| Total Expenses (Quarterly) | 269.59M |
| EPS Diluted (Quarterly) | 1.87 |
| Gross Profit Margin (Quarterly) | 65.37% |
| Profit Margin (Quarterly) | 35.43% |
| Earnings Yield | 8.26% |
| Operating Earnings Yield | 8.51% |
| Normalized Earnings Yield | 6.638 |